Dr Reddys Laboratories (RDY) EBIT Growth (3y) (2012 - 2023)
Dr Reddys Laboratories (RDY) EBIT Growth (3y) (2012 - 2023) Analysis & Trends
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | EBIT Growth (3y) (Qtr) |
|---|---|---|---|---|---|
| 1 | Haleon | 43.94 Bn | 42.97 Bn | - | - |
| 2 | Teva Pharmaceutical Industries | 43.08 Bn | 39.43 Bn | 2.15 Bn | 29.31% |
| 3 | Zoetis | 31.54 Bn | 29.87 Bn | 1.05 Bn | 4.24% |
| 4 | Takeda Pharmaceutical | 28.60 Bn | 22.80 Bn | 5.10 Bn | 0.90% |
| 5 | United Therapeutics | 22.12 Bn | 19.46 Bn | 683.80 Mn | 1.82% |
| 6 | Viatris | 18.75 Bn | 17.86 Bn | 1.46 Bn | -74.25% |
| 7 | Neurocrine Biosciences | 15.50 Bn | 15.11 Bn | 935.80 Mn | 27.21% |
| 8 | Elanco Animal Health | 11.69 Bn | 11.16 Bn | 798.00 Mn | 35.42% |
| 9 | Dr Reddys Laboratories | 10.13 Bn | 9.96 Bn | - | - |
| 10 | Alkermes | 8.09 Bn | 7.43 Bn | 397.90 Mn | -59.74% |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2023 | 23.55% |
| Mar 31, 2023 | 24.45% |
| Sep 30, 2022 | 13,360.84% |
| Jun 30, 2021 | 32.54% |
| Mar 31, 2021 | 10.48% |
| Sep 30, 2020 | -44.85% |
| Sep 30, 2019 | -39.80% |
| Mar 31, 2019 | -0.59% |
| Dec 31, 2018 | -5.76% |
| Sep 30, 2018 | -10.04% |
| Jun 30, 2018 | -20.82% |
| Dec 31, 2017 | -26.44% |
| Sep 30, 2017 | -17.47% |
| Dec 31, 2016 | -14.32% |
| Sep 30, 2016 | -7.17% |
| Mar 31, 2016 | 17.65% |
| Dec 31, 2015 | -12.22% |
| Sep 30, 2015 | -6.17% |
| Jun 30, 2015 | -70.04% |
| Dec 31, 2014 | -71.36% |